ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

3.30
Delayed Data
As of 4:00pm ET
 +0.04 / +1.23%
Today’s Change
2.66
Today|||52-Week Range
7.25
-30.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues4.3M6.9M6.4M146.0K
 
 
 
 
 
Depreciation And Amortization357.0K290.0K369.0K573.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses114.1M171.9M59.5M53.5M
 
 
 
 
 
Research And Development96.8M157.8M45.1M34.1M
 
 
 
 
 
Total Operating Expenses114.4M172.2M59.9M54.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-110.1M-165.3M-53.5M-53.9M
 
 
 
 
 
Extraordinary Credit0.000.000.00158.0K
 
 
Extraordinary Charge-10.0M-124.0K-1.3M0.00
 
 
 
 
Other Expenses12.0K134.0K465.0K631.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-120.1M-165.3M-54.3M-53.1M
 
 
 
 
 
Preferred Dividend0.00-7.1M-18.9M-17.0M
 
 
 
 
Extraordinary Items0.000.000.00207.4M
 
 
Net Income-120.1M-165.3M-54.3M-53.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS125.4M130.4M136.9M143.5M
 
 
 
 
 
Shares To Calculate EPS Diluted125.4M130.4M136.9M143.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.96-$1.32-$0.53$0.96
 
 
 
 
 
EPS Diluted-$0.96-$1.32-$0.53-$0.49